MMedication Read More How Will Ozempic and Wegovy Sales Aid NVO’s Upcoming Q4 Results?January 26, 2026 Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its…
MMedication Read More Takeaways on turmoil surrounding FDA fast-track drug programJanuary 18, 2026 WASHINGTON (AP) — A plan to slash drug review times at the Food and Drug Administration is sparking…
MMedication Read More FDA commissioner’s drug review plan sparks alarmJanuary 17, 2026 WASHINGTON (AP) — The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored…
MMedication Read More Eli Lilly’s Most Promising Weight Loss Drug May Come With a Surprising Benefit: Pain ReliefJanuary 16, 2026 Retatrutide’s recent trial results suggest it may be even better than Eli Lilly’s already approved GLP-1 medication, tirzepatide.…
MMedication Read More How Will Mounjaro and Zepbound Sales Aid LLY’s Upcoming Q4 Results?January 16, 2026 Eli Lilly LLY has emerged as a dominant force in the cardiometabolic market, driven by strong demand for its…
HHealthcare Read More The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & JohnsonJanuary 7, 2026 Chicago, IL – January 6, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog.…
MMedication Read More Vanda Jumps 21% After FDA Approves Motion Sickness TherapyDecember 31, 2025 This article first appeared on GuruFocus. Vanda Pharmaceuticals (NASDAQ:VNDA) jumped roughly 21% in premarket trading after the U.S.…
HHealthcare Read More Lilly and Novo Cut GLP-1 Prices as Pill Approvals Expand AccessDecember 31, 2025 This article first appeared on GuruFocus. Weight-loss drugs known as GLP-1s are increasingly reshaping healthcare and the pharmaceutical…
HHealthcare Read More Novo Nordisk just pulled off something nobody saw comingDecember 31, 2025 Novo Nordisk just got a big win from the FDA, and it could change the weight-loss medicine industry…
HHealthcare Read More China’s new commercial insurance model could broaden access to Alzheimer’s drugsDecember 23, 2025 ChiÂna’s new comÂmerÂcial inÂsurÂance forÂmuÂlaÂry looks to exÂpand paÂtient acÂcess to Alzheimer’s disÂease medÂiÂcines from Eli LilÂly and…
MMedication Read More Eli Lilly’s pill solves the biggest problem with weight lossDecember 21, 2025 Losing weight hasn’t quite been the hardest part of modern obesity treatment. Keeping it off is. That’s exactly…
MMedication Read More Oh no, Ozempic! Eli Lilly’s New Weight-Loss Drug KOs Rival TreatmentsDecember 13, 2025 How do you swear in Danish? Our AI chatbots are much too polite to help us out here,…